Clinical Cancer Research

New Funding Opportunity: Patient-Centric Clinical Trial Team Science Awards July 19, 2022 The Melanoma Research Alliance (MRA) is pleased to announce a Special Opportunity RFP for Team Science Awards focused on patient-centric clinical trials, jointly funded by The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and MRA. MRA and RTFCCR will jointly support two team awards …

New Funding Opportunity: Patient-Centric Clinical Trial Team Science Awards Read More »

Lithuania liberalizes labor migration July 14, 2022 We are excited to celebrate liberalization of labor migration of non-EU nationals passed into law in late June by the Lithuanian parliament. This takes place just under a year after the team at Lithuanian Free Market Institute (LFMI) initiated discussions on systemic reform to address looming demographic and labor market …

Lithuania liberalizes labor migration Read More »

Scientists discover genes that affect the risk of developing pre-leukaemia July 14, 2022 The discovery of 14 inherited genetic changes which significantly increase the risk of a person developing a symptomless blood disorder associated with the onset of some types of cancer and heart disease is published today in Nature Genetics. The finding, made in …

Scientists discover genes that affect the risk of developing pre-leukaemia Read More »

Going the extra mile for people with pancreatic cancer July 12, 2022 BRUSSELS – The Anticancer Fund is partnering with the Rising Tide Foundation for Clinical Cancer Research to support a trial testing a novel strategy in the treatment of patients with pancreatic cancer. As people with pancreatic cancer are currently lacking treatment options, the …

Going the extra mile for people with pancreatic cancer Read More »

RTFCCR grantee update: Impact of DNA mutations on lifelong blood cell production uncovered July 1, 2022 Researchers discover how leukaemia-associated gene mutations steadily commandeer blood cell production over a lifetime, and how these changes relate to ageing and cancer development. New research by scientists at the Wellcome Sanger Institute, the Cambridge Stem Cell Institute, EMBL’s …

RTFCCR grantee update: Impact of DNA mutations on lifelong blood cell production uncovered Read More »

The Weizmann Institute & Rising Tide Foundation partnership February 4, 2022 Over the years, the Weizmann Institute and Rising Tide Foundation have developed a highly successful partnership supporting a spectrum of translational cancer researchers who are making major contributions to the understanding of cancer and offering new avenues for potential treatment. Our first collaboration spanned …

The Weizmann Institute & Rising Tide Foundation partnership Read More »

Join us in Celebrating World Cancer Day! February 4, 2022 Due to the great support received we are very proud to confirm that our first virtual art exhibition Patient Arts for Health turns into a continuous virtual art exhibition! We continue to collect and curate patient art offering new insights on what quality of life means. Our goal is to stimulate patients, family …

Join us in Celebrating World Cancer Day! Read More »

RTF & RTFCCR welcome new Board Members: Elena Leontjeva & Ing. Hubert Bertsch December 22, 2021 We are delighted to announce new additions to our Boards of Directors. Elena Leontjeva joins Rising Tide Foundation Board of Directors; and Ing. Hubert Bertsch joins the Rising Tide Foundation for Clinical Cancer Research Board of Directors. Elena Leontjeva co-founded the Lithuanian Free Market …

RTF & RTFCCR welcome new Board Members: Elena Leontjeva & Ing. Hubert Bertsch Read More »

New addition to the RTFCCR Team – Welcome Zoraide! December 22, 2021 We are delighted to announce Zoraide Granchi joins our team in Schaffhausen as Scientific Program Manager. Zoraide holds both bachelor’s and master’s degrees in Molecular Biology from the University of Pisa, as well as a Ph.D. in Molecular Life Science from the University of Zurich. …

New addition to the RTFCCR Team – Welcome Zoraide! Read More »